arius research

rebrand + online launch

The Canadian biotech firm, in the vanguard of discovering and developing the next wave of antibody therapeutics, and on the heels of phase approvals of candidates from their antibody generation engine, needed a much stronger presence to activate, amplify and communicate their progression with key stakeholders. A complete rebrand together with adding an online component and strengthening their overall marketing investment to partners, brokers and investors was advised. Shown: the new identity and site.

strategy / concept / direction / design